Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedApr 26, 2024
DataAggregated Company Financials
Companies202
  • 7D-0.8%
  • 3M0.7%
  • 1Y-5.5%
  • YTD-0.8%

Over the last 7 days, the Healthcare industry has dropped 1.1%, driven by a pullback from PharmaEssentia of 4.3%. On the other hand Pegavision is actually up 12%. Overall the industry is down 4.6% in 12 months. Looking forward, earnings are forecast to grow by 55% annually.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Apr 2024NT$1.4tNT$228.8bNT$4.2b25.6x336.8x6.3x
Sun, 24 Mar 2024NT$1.4tNT$228.8bNT$7.5b25.4x191x6.3x
Tue, 20 Feb 2024NT$1.4tNT$225.8bNT$6.5b25.6x219.8x6.3x
Thu, 18 Jan 2024NT$1.4tNT$224.9bNT$6.0b24.7x228.8x6.1x
Sat, 16 Dec 2023NT$1.4tNT$224.7bNT$5.9b25.4x241.2x6.3x
Mon, 13 Nov 2023NT$1.4tNT$225.2bNT$7.7b25.3x180.1x6.1x
Wed, 11 Oct 2023NT$1.4tNT$225.3bNT$8.3b25.5x166.4x6.1x
Fri, 08 Sep 2023NT$1.4tNT$225.2bNT$8.4b25.7x163x6.1x
Sun, 06 Aug 2023NT$1.4tNT$226.8bNT$11.3b24.8x124.4x6.2x
Tue, 04 Jul 2023NT$1.5tNT$226.5bNT$11.6b26x126.1x6.4x
Thu, 01 Jun 2023NT$1.4tNT$225.8bNT$13.7b23.3x105x6.4x
Sat, 29 Apr 2023NT$1.4tNT$220.2bNT$12.1b23.2x119.1x6.6x
Mon, 27 Mar 2023NT$1.4tNT$219.8bNT$12.4b21.1x114.5x6.5x
Wed, 22 Feb 2023NT$1.4tNT$214.5bNT$13.6b21.9x106x6.7x
Fri, 20 Jan 2023NT$1.3tNT$214.5bNT$13.8b20.1x94.3x6.1x
Sun, 18 Dec 2022NT$1.3tNT$214.5bNT$14.1b20x93.7x6.2x
Tue, 15 Nov 2022NT$1.2tNT$214.1bNT$14.9b17.7x81.2x5.7x
Thu, 13 Oct 2022NT$1.2tNT$207.4bNT$10.8b19.2x111.5x5.8x
Sat, 10 Sep 2022NT$1.4tNT$207.4bNT$10.7b21.6x132.4x6.9x
Mon, 08 Aug 2022NT$1.2tNT$200.0bNT$10.1b21.9x122.6x6.2x
Wed, 06 Jul 2022NT$1.2tNT$199.0bNT$9.8b22.5x119.9x5.9x
Fri, 03 Jun 2022NT$1.2tNT$207.9bNT$10.7b22.1x112.8x5.8x
Sun, 01 May 2022NT$1.2tNT$206.0bNT$12.2b23.2x102.6x6.1x
Tue, 29 Mar 2022NT$1.2tNT$202.4bNT$14.8b23.2x84x6.1x
Thu, 24 Feb 2022NT$1.2tNT$202.2bNT$14.2b23.1x85.3x6x
Sat, 22 Jan 2022NT$1.1tNT$202.1bNT$14.1b21.7x79.2x5.5x
Mon, 20 Dec 2021NT$1.2tNT$202.1bNT$14.1b21.8x83.7x5.8x
Wed, 17 Nov 2021NT$1.0tNT$201.4bNT$15.3b19.3x67x5.1x
Fri, 15 Oct 2021NT$994.0bNT$197.1bNT$14.2b20.2x70.1x5x
Sun, 12 Sep 2021NT$1.0tNT$197.1bNT$14.2b21.9x73.6x5.3x
Tue, 10 Aug 2021NT$1.1tNT$197.0bNT$14.1b22.6x75x5.4x
Mon, 03 May 2021NT$1.1tNT$191.4bNT$14.8b22.1x72x5.6x
Price to Earnings Ratio

72x


Total Market Cap: NT$1.1tTotal Earnings: NT$14.8bTotal Revenue: NT$191.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Sector Price to Earnings3Y Average 124.2x202220232024
Current Industry PE
  • Investors are optimistic on the Taiwanese Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 336x which is higher than its 3-year average PE of 124x.
  • The industry is trading close to its 3-year average PS ratio of 6.0x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 34% per year over the last three years.
  • Meanwhile revenues for these companies have grown 6.1% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

TW Market-2.26%
Healthcare-0.78%
Medical Equipment1.62%
Life Sciences-0.17%
Pharma-0.95%
Healthtech-1.41%
Healthcare Services-1.63%
Biotech-1.64%
Industry PE
  • Investors are most optimistic about the Healthtech industry, which is trading close to its 3-year average PE ratio of 109x.
    • It looks like they are confident that earnings will grow faster in the future than they have historically.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 144% over the next 5 years.
  • This is better than its past earnings decline of 12% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 19% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6491 PegavisionNT$520.0014.3%
+NT$5.1b		19.7%PE24.5x
6472 Bora PharmaceuticalsNT$756.007.1%
+NT$5.1b		34.5%PE25.2x
6919 Caliway BiopharmaceuticalsNT$391.006.7%
+NT$3.4b		194.5%PS1400.2x
4743 Oneness BiotechNT$152.504.8%
+NT$3.2b		-28.0%PS797x
6620 Handa PharmaceuticalsNT$133.5011.7%
+NT$2.0b		-22.8%PE25.9x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6919

NT$391.00

Caliway Biopharmaceuticals

7D

6.7%

1Y

194.5%

6782

NT$253.00

Visco Vision

7D

8.8%

1Y

-13.7%

6491

NT$520.00

Pegavision

7D

14.3%

1Y

19.7%

4147

NT$82.50

TaiMed Biologics

7D

-0.7%

1Y

-30.4%

6562

NT$15.85

UBI Pharma

7D

-16.8%

1Y

-60.8%

6620

NT$133.50

Handa Pharmaceuticals

7D

11.7%

1Y

-22.8%

3218

NT$240.50

Universal Vision Biotechnology

7D

-2.4%

1Y

-36.4%

6472

NT$756.00

Bora Pharmaceuticals

7D

7.1%

1Y

34.5%

Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Apr 10
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

6535

NT$171.50

Lumosa Therapeutics

7D

-5.5%

1Y

304.0%

6785

NT$290.00

Alar Pharmaceuticals

7D

-4.4%

1Y

85.3%

6986

NT$62.20

HeXun Biosciences

7D

-8.4%

1Y

n/a

6875

NT$65.30

Pharmosa Biopharm

7D

-5.6%

1Y

-18.9%

4157

NT$15.50

TaiGen Biopharmaceuticals Holdings

7D

-5.8%

1Y

0.6%

6547

NT$52.00

Medigen Vaccine Biologics

7D

7.2%

1Y

-21.1%

4743

NT$152.50

Oneness Biotech

7D

4.8%

1Y

-28.0%

6550

NT$66.10

Polaris Group

7D

3.3%

1Y

-30.4%